BGI Genomics Monthly Spotlight - December 2023
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
GENOLIFE and BGI Genomics Partner to Enhance Reproductive Health in Vietnam
BGI Genomics completed the first-ever NIFTY? technology transfer program in Vietnam. NIFTY?, its proprietary NIPT product, will be utilized by the GENOLIFE Genetic Technology Institute laboratory based in Hanoi.
Davos Communications Awards 2023 - BGI Genomics Honored for Its Social Media Impact
BGI Genomics has won the Instagram Campaign (Gold) at the Davos Communications Awards. These Awards honor the best teams and campaigns that have leveraged insights and innovation to achieve measurable business outcomes.
Awareness, Accessibility, and Affordability are Crucial for the Early Detection of Thalassemia
Dr. Androulla Eleftheriou, Executive Director, TIF, and Dr. Peng Zhiyu, Deputy General Manager, BGI Genomics, shared their insights on how to enhance thalassemia awareness programs and screening.
Medical Sciences Dean - Elevate Trust to Enhance Thalassemia Screening in Thailand
Professor Sakorn Pornprasert, Dean, Faculty of Associated Medical Sciences, Chiang Mai University, offered his insights on how to enhance thalassemia screening in Thailand.
Beating Colorectal Cancer with Early Screening and Detection: Patient's Voice
Ingrid Hricová is a resilient voice in the fight against colorectal cancer. In this powerful narrative, she shares her insights on using COLOTECT? and the importance of early screening.
Pioneering Precision Medicine in Saudi Arabia Through Innovation
We interview Dr. Yusra Alyafee, Laboratory Director, Genalive. Its mission aligns with Saudi Vision 2030, focusing on preventive medicine and addressing genetic disorders through advanced screening technologies.